Therabody Acquires Embr Labs’ Thermal Technology

Therabody has acquired Embr Labs’ thermal-wellness technology, including intellectual property associated with the wearable Embr Wave device.

The transaction expands Therabody’s capabilities in temperature-based wellness and women’s health. Financial terms were not disclosed.

Wearable Temperature Management

Embr Labs developed Embr Wave as a wearable device that provides localized cooling or warming sensations at the wrist.

The technology has been positioned as a non-drug option for people experiencing hot flashes and other forms of temperature discomfort. Embr Labs also worked on AI-driven capabilities intended to anticipate hot flashes and adjust thermal support.

Therabody plans to apply Embr’s research and intellectual property to a new generation of products.

The acquisition brings together Embr’s work in personalized thermal stimulation with Therabody’s existing product-development, research, and commercialization resources.

Expanding Women’s Health Research

Therabody intends to continue clinical research around thermal wellness and symptoms associated with perimenopause, menopause, and later stages of life.

The company said women’s health will remain an important area of product development. It plans to maintain the evidence-focused approach used by Embr while exploring how temperature technology can be incorporated into a broader wellness portfolio.

Embr Labs’ technology was developed from research conducted at the Massachusetts Institute of Technology.

KEY QUOTES:

We are thrilled that Therabody will carry our next-generation temperature technology forward. From developing the original Embr Wave to pioneering AI-driven hot flash prediction, our goal has always been about one thing: delivering real, immediate relief to the people who need it most. Therabody stands at the forefront of combining rigorous science with advanced technology, and their vision for the future of wellness aligns perfectly with our own.

Matt Smith, CTO and Co-Founder of Embr Labs

Hot flashes affect most women throughout their perimenopause, menopause, and beyond. The Embr Wave was created to offer women a natural solution for controlling hot flashes and optimizing overall quality of life. I am so excited that Therabody’s team will now harness the Wave’s extraordinary promise in the development of the next-generation technology. This is a game changer for women’s health.

Dr. Pamela Peeke, Former Chief Medical Officer of Embr Labs and Member of Therabody’s Scientific Advisory Board

Women make up half of the population, so supporting their health and well-being through every stage of life is a clear priority for us. Embr has taken an evidence-first approach from the start, and that’s the standard we’ll continue to hold as we lead the next phase of clinical research and product development.

Dr. Rachelle Reed, Head of Scientific Research and Communication at Therabody